Ananda Devices Inc.: federal grants and contributions: 5 agreements; $1.5M value; 2 departments; 3 programs.
Assay record ASY-CA-1NW6W8L0H6 · Cite as: Assay Systems, “Ananda Devices Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/ananda-devices-inc/
Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.
The enterprise has developed a first-class, patent protected technology platform to produce human neuromuscular junction-on-a-chip. The technology has been validated by a leading pharmaceutical company to accelerate toxicity and efficacy tests leading to regulatory approval of two new therapeutic candidates. The FDA is collaborating to qualify this cutting-edge chip technology as a drug discovery tool to replace animal-based toxicity assays. The successful integration of the technology will directly impact drug development and toxicity testing, enhancing the FDA's regulatory processes, reviews
Marketing strategy: The project aims to increase sales for a biotech company.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The project will support development of intellectual property capacity within the firm.
All grants from Canada Economic Development for Quebec Regions
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.